Cargando…
Recent Advances in Gene Therapy for Familial Hypercholesterolemia: An Update Review
(1) Background: Existing lipid-lowering therapies have difficulty in achieving lipid target levels in patients with familial hypercholesterolemia (FH), especially in the treatment of patients with homozygous familial hypercholesterolemia. (2) Method: All of the literature data containing “Familial h...
Autores principales: | Fu, Qingan, Hu, Lijuan, Shen, Tianzhou, Yang, Renqiang, Jiang, Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699383/ https://www.ncbi.nlm.nih.gov/pubmed/36431249 http://dx.doi.org/10.3390/jcm11226773 |
Ejemplares similares
-
Screening and clinical characteristics analysis of familial hypercholesterolemia in a tertiary public hospital
por: Shen, Tianzhou, et al.
Publicado: (2023) -
Causal effect of gallstone disease on the risk of coronary heart disease or acute myocardial infarction: a Mendelian randomization study
por: Fu, Qingan, et al.
Publicado: (2023) -
Recent Advances on Familial Hypercholesterolemia in Children and Adolescents
por: Mainieri, Francesca, et al.
Publicado: (2022) -
Familial hypercholesterolemia – treatment update in children, systematic review
por: Ziółkowska, Sabina, et al.
Publicado: (2022) -
An update on lipid apheresis for familial hypercholesterolemia
por: Taylan, Christina, et al.
Publicado: (2022)